Annual report pursuant to Section 13 and 15(d)

Stockholders Equity and StockBased Compensation (Details 2)

v3.23.1
Stockholders Equity and StockBased Compensation (Details 2) - $ / shares
 12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Weighted average exercise price, granted $ 6.17 $ 6.72
Non Vested Stock Option    
Shares, Non- vested Beginning 11,766 49,726
Shares, Granted 18,852 58,164
Shares, vested (19,228) (96,124)
Shares, non-vested, end of period 11,390 11,766
Weighted average exercise price, Beginning $ 5.71 $ 9.71
Weighted average exercise price, granted 6.17 6.72
Weighted average exercise price, vested 6.17 8.40
Weighted average exercise price, forfeited 0 0
Weighted average exercise price, end of period 5.69 5.71
Weighted average fair value grant date, beginning 4.25 7.44
Weighted average fair value grant date, granted 3.98 2.58
Weighted average fair value grant date, vested 3.90 4.89
Weighted average fair value grant date, forfeited 0 0
Weighted average fair value grant date, end of period $ 4.39 $ 4.25